earnings
Bausch Health Caps 2025 with $1.7B Debt Refinancing and 13% EBITDA Growth (BHC Q4 2025 Earnings Call)
Bausch Health successfully closed out a transformational 2025, delivering an 11th consecutive quarter of revenue and earnings growth while executing a massive $1.7 billion debt exchange. With near-term debt walls removed and the core gastroenterology and international franchises performing strongly, management is now prioritizing strategic business development and a patient approach to monetizing its 88% stake in Bausch + Lomb.